Potential New Treatment for Acute Heart Failure Presented at the Heart Failure 2019 Congress
TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system
Clinical Trials
Sat, 25/05/2019 - 06:30
Thu, 09/05/2019 - 07:00
Cell encapsulation for transport of cells and tissues at room temperature
Tue, 12/03/2019 - 07:00
Unique management tool for minimizing costs, drug waste and risk
Thu, 24/01/2019 - 13:00
Call for the world’s greatest minds to tackle the world’s biggest killers
The British Heart Foundation’s Big Beat Challenge is now accepting proposals
Mon, 05/11/2018 - 07:30
Coventry, UK, 5th November 2018 / Sciad Newswire / Medherant, a developer of innovative transdermal drug delivery treat
Thu, 27/09/2018 - 08:00
Motherwell, Scotland, 27th September 2018 / Sciad Newswire / Clyde Biosciences, the leader in cardiac cell function assess
Sat, 25/08/2018 - 00:15
British Heart Foundation to tackle the suffering and devastation caused by heart and circulatory diseases with historic research award
Wed, 01/08/2018 - 07:30
London, UK, 1st August 2018 / Sciad Newswire / ReViral, an antiviral drug discovery and development company, focused on di
Mon, 05/02/2018 - 07:30
ReViral’s RV521 fusion inhibitor produces highly significant reduction in viral load and clinical symptoms
Wed, 13/12/2017 - 10:00
13th December 2017 / Sciad Newswire / Amyndas Pharmaceuticals, which is committed to developing innovative therapeutics for